Genomics

Dataset Information

0

A third generation therapeutic vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH

ABSTRACT: Whole  blood transcriptomic profiling indicated that CHAd63-KH induced innate immune responses characterized by an interferon signature and the presence of activated dendritic cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE98212 | GEO | 2017/04/26

SECONDARY ACCESSION(S): PRJNA384259

REPOSITORIES: GEO

Json Xml

Similar Datasets

Unknown A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH.
| S-EPMC5443534 | biostudies-literature
Unknown Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan.
| S-EPMC8261165 | biostudies-literature
Unknown KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis.
| S-EPMC3147330 | biostudies-literature
Unknown Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse.
| S-EPMC6795025 | biostudies-literature
Unknown Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: A cohort study from Bangladesh.
| S-EPMC6711542 | biostudies-literature
Unknown A gp63 based vaccine candidate against Visceral Leishmaniasis.
| S-EPMC3046035 | biostudies-literature
Unknown Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
| S-EPMC5720812 | biostudies-literature
Unknown Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
| S-EPMC7568327 | biostudies-literature
Unknown Transcriptome-wide effect profile of HuR inhibitor KH-3
2019-04-05 | GSE129362 | GEO
Unknown Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
| S-EPMC3358331 | biostudies-other